Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
dos Santos, Rafael Guimarães
Bouso, José Carlos
Hallak, Jaime E. C.
Text and Data Mining valid from 2019-10-28
Version of Record valid from 2019-10-28
23 October 2018
12 September 2019
28 October 2019
Ethics approval and consent to participate
The authors declare that they have no competing interests.